Atopic dermatitis is not associated with actinic keratosis: cross-sectional results from the Rotterdam study

British Journal of Dermatology

Volumn 175, Issue 1, 2016, Pages 89-94

  Hajdarbegovic, E ^a   Blom, H ^a   Verkouteren, J A C ^a   Hofman, A ^a   Hollestein, L M ^a   Nijsten, T ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; BASAL CELL CARCINOMA; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; KERATINOCYTE; MAJOR CLINICAL STUDY; MALE; ODDS RATIO; PRIORITY JOURNAL; SKIN EXAMINATION; SQUAMOUS CELL CARCINOMA;

EID: 84982969106     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.14423     Document Type: Article

References (33)

1. Williams H, Flohr C. How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol 2006; 118:209–13.
2. Bieber T. Atopic dermatitis. N Engl J Med 2008; 358:1483–94.
3. Hajdarbegovic E, Verkouteren J, Balak D. Non-melanoma skin cancer: the hygiene hypothesis. Med Hypotheses 2012; 79:872–4.
4. Mildner M, Jin J, Eckhart L et al. Knockdown of filaggrin impairs diffusion barrier function and increases UV sensitivity in a human skin model. J Invest Dermatol 2010; 130:2286–94.
5. Denecker G, Hoste E, Gilbert B et al. Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol 2007; 9:666–74.
6. Guinea-Viniegra J, Zenz R, Scheuch H et al. Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17. J Clin Invest 2012; 122:2898–910.
7. Strid J, Sobolev O, Zafirova B et al. The intraepithelial T cell response to NKG2D-ligands links lymphoid stress surveillance to atopy. Science 2011; 334:1293–7.
8. Dupuy A, Dehen L, Bourrat E et al. Accuracy of standard dermoscopy for diagnosing scabies. J Am Acad Dermatol 2007; 56:53–62.
9. Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet 2010; 375:673–85.
10. He W, Zhu F, Ma X et al. Actinic skin damage and mortality – the First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. PLoS ONE 2011; 6:e19907.
11. Flohil SC, van der Leest RJ, Dowlatshahi EA et al. Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study. J Invest Dermatol 2013; 133:1971–8.
12. El-Khateeb EA, Ragab NF, Mohamed SA. Epidermal photoprotection: comparative study of narrowband ultraviolet B minimal erythema doses with and without stratum corneum stripping in normal and vitiligo skin. Clin Exp Dermatol 2011; 36:393–8.
13. Hong SP, Kim MJ, Jung MY et al. Biopositive effects of low-dose UVB on epidermis: coordinate upregulation of antimicrobial peptides and permeability barrier reinforcement. J Invest Dermatol 2008; 128:2880–7.
14. Barresi C, Stremnitzer C, Mlitz V et al. Increased sensitivity of histidinemic mice to UVB radiation suggests a crucial role of endogenous urocanic acid in photoprotection. J Invest Dermatol 2011; 131:188–94.
15. Skaaby T, Husemoen LL, Thyssen JP et al. Filaggrin loss-of-function mutations and incident cancer: a population-based study. Br J Dermatol 2014; 171:1407–14.
16. Dyer RK, Weinstock MA, Cohen TS et al. Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial. J Invest Dermatol 2012; 132:2544–51.
17. Arana A, Wentworth CE, Fernández-Vidaurre C et al. Incidence of cancer in the general population and in patients with or without atopic dermatitis in the U.K. Br J Dermatol 2010; 163:1036–43.
18. Jensen AO, Svaerke C, Körmendiné Farkas D et al. Atopic dermatitis and risk of skin cancer: a Danish nationwide cohort study (1977–2006). Am J Clin Dermatol 2012; 13:29–36.
19. Hagstromer L, Ye W, Nyrén O, Emtestam L. Incidence of cancer among patients with atopic dermatitis. Arch Dermatol 2005; 141:1123–7.
20. Hwang CY, Chen YJ, Lin MW et al. Cancer risk in patients with allergic rhinitis, asthma and atopic dermatitis: a nationwide cohort study in Taiwan. Int J Cancer 2012; 130:1160–7.
21. Milan T, Verkasalo PK, Kaprio J, Koskenvuo M. Lifestyle differences in twin pairs discordant for basal cell carcinoma of the skin. Br J Dermatol 2003; 149:115–23.
22. Cheng J, Zens MS, Duell EJ et al. History of allergy and atopic dermatitis in relation to squamous cell and basal cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev 2015; 24:749–54.
23. Ming ME, Levy R, Hoffstad O et al. The lack of a relationship between atopic dermatitis and nonmelanoma skin cancers. J Am Acad Dermatol 2004; 50:357–62.
24. Hofman A, Darwish Murad S, van Duijn CM et al. The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol 2013; 28:889–926.
25. Bieber T, Bussmann C. Atopic dermatitis. In: Dermatology (Bolognia J, Jorizzo J, Schaffer J, eds), 3rd edn. Amsterdam: Elsevier Saunders, 2012; 203–16.
26. Paul C, Maumus-Robert S, Mazereeuw-Hautier J et al. Prevalence and risk factors for xerosis in the elderly: a cross-sectional epidemiological study in primary care. Dermatology 2011; 223:260–5.
27. Jacquet A. Innate immune responses in house dust mite allergy. ISRN Allergy 2013; 2013:735031.
28. Zeppa L, Bellini V, Lisi P. Atopic dermatitis in adults. Dermatitis 2011; 22:40–6.
29. Wakkee M, Hollestein LM, Nijsten T. Multivariable analysis. J Invest Dermatol 2014; 134:e20.
30. Cipolat S, Hoste E, Natsuga K et al. Epidermal barrier defects link atopic dermatitis with altered skin cancer susceptibility. Elife 2014; 3:e01888.
31. Lindelof B, Granath F, Tengvall-Linder M, Ekbom A. Allergy and cancer. Allergy 2005; 60:1116–20.
32. Taylor B, Wadsworth J, Wadsworth M, Peckmah C. Changes in the reported prevalence of childhood eczema since the 1939–45 war. Lancet 1984; 2:1255–7.
33. Kaae J, Thyssen JP, Johansen JD et al. Filaggrin gene mutations and risk of basal cell carcinoma. Br J Dermatol 2013; 169:1162–4.